Insider Transactions in Q3 2025 at Heartflow, Inc. (HTFL)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2025
|
Bain Capital Life Sciences Investors, LLC |
BUY
Conversion of derivative security
|
Indirect |
12,448,158
+26.68%
|
$186,722,370
$15.2 P/Share
|
|
Aug 11
2025
|
Jeffrey C Lightcap Director |
BUY
Conversion of derivative security
|
Indirect |
6,697,556
+50.0%
|
-
|
|
Aug 11
2025
|
Casey M Tansey Director |
BUY
Conversion of derivative security
|
Direct |
16,447
+50.0%
|
-
|
|
Aug 11
2025
|
Casey M Tansey Director |
BUY
Conversion of derivative security
|
Indirect |
3,171,062
+50.0%
|
-
|
|
Aug 11
2025
|
Timothy C Barabe Director |
BUY
Conversion of derivative security
|
Direct |
131,578
+43.87%
|
-
|
|
Aug 11
2025
|
Marie L. Jones Chief Accounting Officer, VP |
BUY
Conversion of derivative security
|
Direct |
6,578
+39.22%
|
-
|
|
Aug 11
2025
|
Vikram Verghese Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
9,516
+6.14%
|
-
|
|
Aug 11
2025
|
William C Weldon Director |
BUY
Conversion of derivative security
|
Direct |
136,286
+41.44%
|
-
|
|
Aug 07
2025
|
Marie L. Jones Chief Accounting Officer, VP |
BUY
Grant, award, or other acquisition
|
Direct |
3,618
+50.0%
|
-
|
|
Aug 07
2025
|
Campbell Rogers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,052
+50.0%
|
-
|
|
Aug 07
2025
|
Vikram Verghese Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,052
+13.42%
|
-
|
|
Aug 07
2025
|
John C.M. Farquhar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,868
+12.14%
|
-
|